RECRUITINGOBSERVATIONAL

Harm Reduction in HIV Primary Care for PLWH Who Use Drugs

Impact of Harm Reduction Care in HIV Clinical Settings on Stigma and Health Outcomes

About This Trial

People living with HIV (PLWH) who use drugs experience significant health disparities including lower rates of retention in HIV care and higher rates of unsuppressed viral load, resulting in secondary infections and increased mortality. The proposed study will used mixed methods to explore (a) the relationship between healthcare providers' attitudes towards working with PLWH who use drugs and providers' acceptance and practice of structural and relational harm reduction; (b) the degree to which relational harm reduction moderates the effect of intersectional stigma experienced in healthcare settings on patients' perceptions of their relationship with providers; (c) the degree to which structural HR moderates the relationship between the patient-provider relationship and clinical outcomes, and (d) whether patient-perceived HR approaches to care are directly associated with HIV clinical outcomes. The study will also use these findings to inform the development and pre-testing of an intervention to operationalize harm reduction in HIV clinical settings, using stakeholder-engaged and human-centered design approaches, presenting a novel path to reducing HIV health inequities for PLWH who use drugs.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Providers' Inclusion Criteria - Working at one of our 3 study sites (UPMC HIV/AIDS Program, Positive Health Clinic, or 1917 Clinic) or one of their partner sites offering substance use treatment (Internal Medicine Recovery Engagement Program, Center for Inclusion Health, or UAB's Outpatient-Based Opioid Treatment Clinic) for at least one year - Providing service or care to PLWH or people who use drugs at high risk for HIV acquisition - Working in one of the following positions: front desk/patient engagement, social worker, nurse, medical assistant, advanced practice provider, or physician - Able to verbally consent, read, and speak English 2. Patient Inclusion Criteria - Living with HIV - Age 18 or older - Able to verbally consent, read, and speak English - Receiving HIV medical care from one of the study sites for at least one year - Lifetime or recent use (past 3 months) of illicit substances (excluding marijuana) or prescription drugs for non-medical reasons in accordance with the NIDA-Modified ASSIST 2.0. Who Should NOT Join This Trial: \- Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: 1. Providers' Inclusion Criteria * Working at one of our 3 study sites (UPMC HIV/AIDS Program, Positive Health Clinic, or 1917 Clinic) or one of their partner sites offering substance use treatment (Internal Medicine Recovery Engagement Program, Center for Inclusion Health, or UAB's Outpatient-Based Opioid Treatment Clinic) for at least one year * Providing service or care to PLWH or people who use drugs at high risk for HIV acquisition * Working in one of the following positions: front desk/patient engagement, social worker, nurse, medical assistant, advanced practice provider, or physician * Able to verbally consent, read, and speak English 2. Patient Inclusion Criteria * Living with HIV * Age 18 or older * Able to verbally consent, read, and speak English * Receiving HIV medical care from one of the study sites for at least one year * Lifetime or recent use (past 3 months) of illicit substances (excluding marijuana) or prescription drugs for non-medical reasons in accordance with the NIDA-Modified ASSIST 2.0. Exclusion Criteria: \-

Treatments Being Tested

BEHAVIORAL

Harm Reduction

Harm reduction aims to reduce negative effects of risky health behaviors without necessarily terminating the behaviors completely.Though often thought of as structural approaches (e.g., policy or syringe services), Harm reduction is also a relational approach to care focusing on non-punitive patient-provider interactions to promote autonomy. The degree to which harm reduction care is offered in study settings and is associated with clinical outcomes is the focus of this study.

Locations (3)

University of Alabama at Birmingham

Birmingham, Alabama, United States

Allegheny Health Network Research Institute

Pittsburgh, Pennsylvania, United States

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States